The thing that I worry about more than loss of exclusivity is this term that I introduced at the AACR meeting -- loss of relevancy" says Susan Galbraith, EVP of Oncology R&D at AstraZeneca.

Understand every aspect of the global economy – and know how to make your next move.

CARLSBAD, Calif. — David Ford joined an exclusive club Monday. He became the third player in the history of the PGA Tour to earn his Tour membership via PGA Tour University class rankings, following ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...

CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca (NASDAQ:AZN)’s experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease ...

CHICAGO — Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death ...

AstraZeneca has unveiled positive trial results for a breast cancer drug that can stop mutating tumours before they start to grow, hoping it will be one of a portfolio of medicines that will propel it ...

David Beckham believes the conduct of some Manchester United players was “not acceptable” on the club’s post-season tour. Ruben Amorim and his squad travelled to Malaysia and Hong Kong off t ...